Nowadays, two valid drug types including memantine and cholinesterase inhibitors as a treatment for AD, are clinically proven to improve memory decline and alertness without hindering AD progression and life expectancy (Weller and Budson 2018). This evidence concerns the gene BCHE and Alzheimer disease.